Chinese People's Liberation Army General Hospital
Beijing, 100000, China
NCT Number: NCT06903520
To explore the occurrence of pancreaticobiliary maljunction (PBM) in the Chinese population, the characteristics of various subtypes, and the relationship between PBM and malignant tumors of the biliary system. To explore the general clinical characteristics of patients with mild bile duct dilation but who have not been clinically diagnosed with choledochal cysts, as well as the relationship between these characteristics and malignant tumors of the biliary system. To develop and evaluate a deep learning method for machine learning of Magnetic resonance cholangiopancreatography (MRCP) images, enabling fully automated detection of pancreaticobiliary maljunction.
Looking for future studies?
Notify MeAll sexes
Observational
Beijing, 100000, China
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Cases that were hospitalized and underwent Magnetic resonance cholangiopancreatography (MRCP) examination at the First Medical Center of Chinese People's Liberation Army General Hospital.
Exclusion criteria
Time frame: 1 year
Chinese PLA General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06111872
Bile Duct Diseases, Biliary Tract Diseases
Cheras, Kuala Lumpur, Malaysia
View Trial DetailsNCT04336722
Bile Duct Diseases, Biliary Atresia
Los Angeles, California, United States
View Trial DetailsNCT06184971
Bile Duct Diseases, Biliary Atresia
Hartford, Connecticut, United States
View Trial DetailsNCT07328204
Bile Duct Diseases, Biliary Atresia
Hangzhou, China
View Trial Details